This observation is in keeping with Melenhorst et al. [58], who demonstrated that a CD4+ population dominated long-lasting CD19-directed CARTs in two CLL patients who showed a sustained CR for more than ten years. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.